Owner Novartis AG

Inventors Badiger, Sangamesh; Chebrolu, Murali; Frederiksen, Mathias; Holzer, Philipp; Hurth, Konstanze; Lueoend, Rainer Martin; Machauer, Rainer; Moebitz, Henrik; Neumann, Ulf; Ramos, Rita; Rueeger, Heinrich; Tintelnot-Blomley, Marina; Veenstra, Siem Jacob; Voegtle, Markus

Agent Davies Collison Cave

Pub. Number AU-A-2010274913

PCT Pub. Number WO2011/009943

Priority 61/363,702 13.07.10 US; 61/258,911 06.11.09 US; 61/228,472 24.07.09 US

Filing date 23 July 2010

Wipo publication date 27 January 2011

C07D 265/30 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

A61K 31/5377 (2006.01)

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups